Search research articles
Contact Us
Filters
Showing results (121-130 of 134) with videos related to
Page
of 14
Sort By:
The Journal of Infectious Diseases
|
July 1, 1995
Human immunodeficiency virus (HIV) type 1 infection status and in vitro susceptibility to HIV infection among high-risk HIV-1-seronegative hemophiliacs
M M Lederman, J B Jackson, B L Kroner, et al.
The Journal of Clinical Investigation
|
July 3, 1998
In vivo analysis of Fas/FasL interactions in HIV-infected patients
A D Badley, D H Dockrell, A Algeciras, et al.
HIV Medicine
|
May 18, 2016
Systemic inflammation and liver damage in HIV/hepatitis C virus coinfection
K V Shmagel, E V Saidakova, N G Shmagel, et al.
The Journal of Infectious Diseases
|
March 9, 1999
Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points
H Wu, D R Kuritzkes, D R McClernon, et al.
The New England Journal of Medicine
|
October 10, 1996
A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team
S M Hammer, D A Katzenstein, M D Hughes, et al.
Clinical Immunology (Orlando, Fla.)
|
February 13, 2001
Characterization of high-risk HIV-1 seronegative hemophiliacs
J R Salkowitz, S F Purvis, H Meyerson, et al.
Mucosal Immunology
|
February 4, 2016
Prevention of SHIV transmission by topical IFN-β treatment
R S Veazey, H A Pilch-Cooper, T J Hope, et al.
AIDS (London, England)
|
March 14, 2000
Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group
H Valdez, K Y Smith, A Landay, et al.
The Journal of Infectious Diseases
|
July 4, 1998
Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315
M M Lederman, E Connick, A Landay, et al.
The Journal of Infectious Diseases
|
December 23, 1999
Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response
E Connick, M M Lederman, B L Kotzin, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 134) with videos related to
Sort By:
Page
of 14
The Journal of Infectious Diseases
|
July 1, 1995
Human immunodeficiency virus (HIV) type 1 infection status and in vitro susceptibility to HIV infection among high-risk HIV-1-seronegative hemophiliacs
M M Lederman, J B Jackson, B L Kroner, et al.
The Journal of Clinical Investigation
|
July 3, 1998
In vivo analysis of Fas/FasL interactions in HIV-infected patients
A D Badley, D H Dockrell, A Algeciras, et al.
HIV Medicine
|
May 18, 2016
Systemic inflammation and liver damage in HIV/hepatitis C virus coinfection
K V Shmagel, E V Saidakova, N G Shmagel, et al.
The Journal of Infectious Diseases
|
March 9, 1999
Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points
H Wu, D R Kuritzkes, D R McClernon, et al.
The New England Journal of Medicine
|
October 10, 1996
A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team
S M Hammer, D A Katzenstein, M D Hughes, et al.
Clinical Immunology (Orlando, Fla.)
|
February 13, 2001
Characterization of high-risk HIV-1 seronegative hemophiliacs
J R Salkowitz, S F Purvis, H Meyerson, et al.
Mucosal Immunology
|
February 4, 2016
Prevention of SHIV transmission by topical IFN-β treatment
R S Veazey, H A Pilch-Cooper, T J Hope, et al.
AIDS (London, England)
|
March 14, 2000
Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group
H Valdez, K Y Smith, A Landay, et al.
The Journal of Infectious Diseases
|
July 4, 1998
Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315
M M Lederman, E Connick, A Landay, et al.
The Journal of Infectious Diseases
|
December 23, 1999
Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response
E Connick, M M Lederman, B L Kotzin, et al.
Page
of 14